Recently, news regarding anemia drugs such as Aranesp, Epogen and Procrit has caused concern among patients and their families. Patients have learned that the drugs could increase the risk of heart attacks and strokes as well as increasing the progression rate of tumors in certain cancers. With the emergence of this news, family members have been left wondering whether the death of their loved ones came too soon. The FDA’s safety warnings of the anemia drugs have been recently strengthened, cautioning that heart attack, death, and cancer progression could be side effects. A newer study has also linked the anemia drugs to an increased risk for patients with myelofibrosis of developing leukemia. Doctors have been warned to use the lowest doses possible of these drugs.
Click here for the full article